Nexium Label Updated With Postmarketing Adverse Events
This article was originally published in The Pink Sheet Daily
Executive Summary
Newly updated Nexium labeling includes postmarketing reports of adverse events including myalgia and hepatitis. The update comes as AstraZeneca is actively promoting the proton pump inhibitor's use with NSAIDs.